Seeking Alpha

Achillion's (ACHN +3.2%) ACH-3102 medicine for chronic hepatitis C viral infections, in...

Achillion's (ACHN +3.2%) ACH-3102 medicine for chronic hepatitis C viral infections, in combination with antiviral drug ribavirin, has performed well so far in a Phase 2a study of 8 patients. The treatment "resulted in the rapid reduction in HCV RNA accompanied by normalization of liver enzymes." The combo also appears to be safe and well tolerated. (PR)
From other sites
Comments (2)
  • kenwilson99
    , contributor
    Comment (1) | Send Message
     
    ACHN Hep C meds will be best in class - this is a great company!
    7 Jan 2013, 01:28 PM Reply Like
  • citynick
    , contributor
    Comments (34) | Send Message
     
    some one explain to me why today was a down day for achn
    8 Jan 2013, 07:28 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs